
Pennant Group (PNTG) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
209.8M
Gross Profit
29.4M
14.00%
Operating Income
12.6M
6.03%
Net Income
8.5M
4.06%
EPS (Diluted)
$0.22
Balance Sheet Metrics
Total Assets
743.6M
Total Liabilities
420.6M
Shareholders Equity
323.0M
Debt to Equity
1.30
Cash Flow Metrics
Operating Cash Flow
850.0K
Free Cash Flow
-23.2M
Revenue & Profitability Trend
Pennant Group Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 695.2M | 544.9M | 473.2M | 439.7M | 391.0M |
Cost of Goods Sold | 601.5M | 477.9M | 414.7M | 391.1M | 336.1M |
Gross Profit | 93.8M | 67.0M | 58.6M | 48.6M | 54.9M |
Gross Margin % | 13.5% | 12.3% | 12.4% | 11.1% | 14.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 50.2M | 36.7M | 34.0M | 36.3M | 31.3M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 50.2M | 36.7M | 34.0M | 36.3M | 31.3M |
Operating Income | 37.4M | 25.2M | 19.7M | 7.6M | 18.9M |
Operating Margin % | 5.4% | 4.6% | 4.2% | 1.7% | 4.8% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 7.0M | 5.9M | 3.8M | 1.9M | 1.2M |
Other Non-Operating Income | 889.0K | 269.0K | -7.0M | -2.9M | 225.0K |
Pre-tax Income | 31.4M | 19.6M | 8.9M | 2.7M | 17.9M |
Income Tax | 7.0M | 5.7M | 1.6M | 582.0K | 2.4M |
Effective Tax Rate % | 22.4% | 29.0% | 18.5% | 21.3% | 13.1% |
Net Income | 24.3M | 13.9M | 7.2M | 2.1M | 15.6M |
Net Margin % | 3.5% | 2.6% | 1.5% | 0.5% | 4.0% |
Key Metrics | |||||
EBITDA | 43.8M | 30.7M | 24.6M | 12.3M | 23.8M |
EPS (Basic) | $0.72 | $0.45 | $0.23 | $0.09 | $0.56 |
EPS (Diluted) | $0.70 | $0.44 | $0.22 | $0.09 | $0.52 |
Basic Shares Outstanding | 31191000 | 29863000 | 29064000 | 28406000 | 28029000 |
Diluted Shares Outstanding | 31191000 | 29863000 | 29064000 | 28406000 | 28029000 |
Income Statement Trend
Pennant Group Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 24.2M | 6.1M | 2.1M | 5.2M | 43.0K |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 81.3M | 61.1M | 53.4M | 53.9M | 47.2M |
Inventory | - | - | - | - | - |
Other Current Assets | 17.3M | 12.9M | 18.3M | 16.7M | - |
Total Current Assets | 122.9M | 80.1M | 73.8M | 75.8M | 59.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 301.8M | 292.2M | 286.4M | 323.4M | 331.1M |
Goodwill | 354.4M | 249.8M | 217.6M | 202.3M | 180.4M |
Intangible Assets | 96.2M | 67.7M | 58.6M | 53.7M | 47.5M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 17.5M | 9.3M | 12.7M | 8.7M | 6.9M |
Total Non-Current Assets | 556.7M | 459.6M | 438.3M | 454.5M | 447.4M |
Total Assets | 679.5M | 539.7M | 512.1M | 530.3M | 507.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 18.7M | 10.8M | 13.6M | 10.6M | 9.8M |
Short-term Debt | 19.7M | 17.1M | 16.6M | 16.1M | 14.1M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 101.7M | 71.5M | 70.2M | 71.6M | 89.0M |
Non-Current Liabilities | |||||
Long-term Debt | 253.4M | 312.5M | 309.9M | 339.1M | 304.9M |
Deferred Tax Liabilities | 1.9M | 1.9M | 0 | - | - |
Other Non-Current Liabilities | 10.6M | 8.3M | 6.3M | 5.3M | 11.9M |
Total Non-Current Liabilities | 265.9M | 322.6M | 316.2M | 344.4M | 316.8M |
Total Liabilities | 367.6M | 394.2M | 386.5M | 416.1M | 405.8M |
Equity | |||||
Common Stock | 35.0K | 29.0K | 29.0K | 28.0K | 28.0K |
Retained Earnings | 57.2M | 34.7M | 21.3M | 14.6M | 11.9M |
Treasury Stock | 65.0K | 65.0K | 65.0K | 65.0K | 65.0K |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 312.0M | 145.5M | 125.7M | 114.2M | 101.2M |
Key Metrics | |||||
Total Debt | 273.1M | 329.6M | 326.6M | 355.2M | 319.0M |
Working Capital | 21.2M | 8.5M | 3.6M | 4.2M | -29.4M |
Balance Sheet Composition
Pennant Group Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 24.3M | 13.9M | 7.2M | 2.1M | 15.6M |
Depreciation & Amortization | 6.1M | 5.1M | 4.9M | 4.8M | 4.7M |
Stock-Based Compensation | 7.8M | 5.4M | 3.1M | 10.0M | 8.3M |
Working Capital Changes | -12.5M | -8.5M | 2.5M | -9.7M | 17.4M |
Operating Cash Flow | 25.7M | 20.4M | 19.9M | 6.0M | 44.1M |
Investing Activities | |||||
Capital Expenditures | -9.0M | -8.1M | -14.2M | -6.3M | -7.3M |
Acquisitions | -48.4M | -21.4M | -10.1M | -13.6M | -33.2M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -70.7M | -30.2M | -24.2M | -20.1M | -41.6M |
Financing Activities | |||||
Share Repurchases | - | - | 0 | 0 | -65.0K |
Dividends Paid | - | - | - | 0 | 0 |
Debt Issuance | - | - | - | - | 52.7M |
Debt Repayment | -374.5M | -181.5M | -118.5M | -81.5M | -63.2M |
Financing Cash Flow | -324.9M | -181.0M | -107.5M | -38.9M | -20.6M |
Free Cash Flow | 30.3M | 25.0M | -5.1M | -24.5M | 43.0M |
Net Change in Cash | -369.9M | -190.8M | -111.8M | -53.0M | -18.1M |
Cash Flow Trend
Pennant Group Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
29.66
Forward P/E
20.87
Price to Book
2.56
Price to Sales
1.04
PEG Ratio
20.87
Profitability Ratios
Profit Margin
3.40%
Operating Margin
6.03%
Return on Equity
11.41%
Return on Assets
4.00%
Financial Health
Current Ratio
1.41
Debt to Equity
105.10
Beta
1.48
Per Share Data
EPS (TTM)
$0.76
Book Value per Share
$8.81
Revenue per Share
$23.17
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
pntg | 776.9M | 29.66 | 2.56 | 11.41% | 3.40% | 105.10 |
HCA Healthcare | 89.3B | 16.02 | -72.79 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 14.2B | 10.12 | 3.80 | 29.65% | 7.18% | 158.70 |
Acadia Healthcare | 1.7B | 11.84 | 0.53 | 4.83% | 4.31% | 73.98 |
Addus HomeCare | 2.1B | 25.37 | 2.06 | 8.54% | 6.51% | 21.75 |
Select Medical | 1.8B | 23.21 | 1.07 | 7.72% | 3.33% | 136.22 |
Financial data is updated regularly. All figures are in the company's reporting currency.